The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy

Alexander Augustyn, L. Jeffrey Medeiros, Ethan B. Ludmir, Jillian Gunther, Penny Fang, Shaoying Li, Chi Young Ok, Mikaela E. Bankston, Vivek Verma, Dario Pasalic, Sairah Ahmed, Loretta J. Nastoupil, Jason R. Westin, Paolo Strati, Sattva S. Neelapu, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, Alma Rodriguez, Luis E. FayadChristopher R. Flowers, Bouthaina S. Dabaja, Chelsea C. Pinnix

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences